Close
Login to MyACC
ACC Members


Not a Member?

The Association of Corporate Counsel (ACC) is the world's largest organization serving the professional and business interests of attorneys who practice in the legal departments of corporations, associations, nonprofits and other private-sector organizations around the globe.

Join ACC

ACC Member Portal and Web Services are back online
ACC's member portal and web services are available following a scheduled upgrade. However, our team is monitoring and resolving issues promptly. Please be sure to reset your password here.
Thank you for your patience. Please contact our team with any questions.

Search Filters
Jeffrey Hunter and Colin Flood, Senior Managing Directors, Ankura Consulting Group, LLC
6 pages

This article discusses potential risks to businesses from generative AI, as well as mitigation strategies, in areas such as cybersecurity, intellectual property, human resources, compliance, marketing, ethics, and criminal law.

Gary Shuster of Coleman & Horowitt, LLP (a Primerus member firm)
7 pages

This article provides a comprehensive look at copyright registration in the United States. Topics covered includes costs, navigating the process, timing considerations, and key benefits.

Resource Details
Interest Area: Intellectual Property
Region: United States
Global Legal Group
282 pages

This guide covers recent developments in artificial development, machine learning and big data laws and regulations across 22 jurisdictions.

Resource Details
Region: Global, China, Cyprus, Czech Republic, Estonia, France, Germany, Greece, Hong Kong, Ireland, Italy, Japan, Malta, Mexico, Netherlands, Poland, Singapore, Switzerland, Taiwan, Turkey, United Arab Emirates, United Kingdom, United States

image

This program originally aired on March 6, 2025. Please note that this program recording is not eligible for CLE/CPD credit.

Cyber threats and regulatory pressures are constantly evolving and exposing your company to new risks. Newfront's experts break down the key trends legal leaders need to watch—from cybersecurity claims and data privacy breach reporting, to recent D&O market developments.


Presented by:

Caryn McDowell
Director & Board Member
California Life Sciences

Eric Long
EVP & Founding Principal
Newfront

Jennifer Wilson
Head of Cyber
Newfront

Brandon Settle
AVP Life Science Practice
Newfront

Dan Lindell
SVP, Executive Risk Solutions Practice
Newfront



image

image

This program originally aired on March 6, 2025. Please note that this program recording is not eligible for CLE/CPD credit.

Litigation risk is a constant concern for life sciences companies, from clinical trials to commercialization. This session will explore key litigation triggers across the product lifecycle and provide practical strategies for in-house counsel to mitigate risk. Through real-world case studies, our panel will share best practices for assessing and managing litigation exposure to protect both products and business operations.

Presented by:

John Alden
General Counsel
FibroGen

Janet Kwuon
Global Head of Litigation and Investigations
Gilead

Alicia Donahue
Partner
Shook Hardy

Lori McGroder
Partner
Shook Hardy

Tom Sullivan
Managing Partner, Boston
Shook Hardy


image

image

This program originally aired on March 5, 2025. Please note that this program recording is not eligible for CLE/CPD credit.

Discover how strategic branding can transform your life sciences company into a market leader. Join Wilson Sonsini experts Alyssa Worsham and Brandon Leahy as they reveal how innovative branding—from proprietary platform names to cutting-edge drug names—can be a game-changer in your IP strategy. Gain insights from Dell Chism, Vice President of Intellectual Property at Centessa Pharmaceuticals, and learn how to capture investor attention and stand out in a competitive landscape.

Presented by:

Dell Chism
Vice President of Intellectual Property
Centessa Pharmaceuticals

Alyssa Worsham
Partner
Wilson Sonsini

Brandon Leahy
Senior Counsel
Wilson Sonsini


image

image

This program originally aired on March 5, 2025. Please note that this program recording is not eligible for CLE/CPD credit.

The patent misuse doctrine can be a formidable defense for licensees in raising claims that could result in the unenforceability of patents. This presentation will explore the doctrine and related licensing issues that arise when negotiating IP license agreements in the life sciences before and after the licensed patents expire. Panelists will discuss best practices for avoiding patent misuse and antitrust issues when licensing intellectual property, while fostering innovation.

Presented by:

Ilan Feuchtwang
General Counsel
Synthego Corporation  

Victoria Kruse
Director of Corporate Transactions
Caribou Biosciences

Jeffrey Smyth
Partner
Finnegan

Brian Kacedon
Partner
Finnegan


image
Barry M. Benjamin, Partner (Kilpatrick), Michael W. O’Neill, General Counsel (Mainstream Engineering Corporation) and John C. Bush, Associate General Counsel (Lyric)

Creative advertising can drive revenue and build brand strength. This article discusses how the legal department can support marketing innovations.

Resource Details
Region: Global, United States
Subscribe to Intellectual Property